Table 4.

Combination therapies with hypomethylating agents in patients with MDS

Combination therapies with hypomethylating agents in patients with MDS

Combination studies were reviewed in Ornstein and Sekeres.54 

N indicates number of patients; and ORR, overall response rate.

*Decrease in hemorrhagic events.

Close Modal

or Create an Account

Close Modal
Close Modal